Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Tezepelumab cuts OCS use in OCS-dependent patients with severe asthma
Patients with severe asthma who were dependent on oral corticosteroid (OCS) were able to reduce their use of maintenance OCS after treatment with the monoclonal antibody tezepelumab, according to findings from the interim analysis of the phase IIIb WAYFINDER trial.
Tezepelumab cuts OCS use in OCS-dependent patients with severe asthma
15 Nov 2023Which factors predict recurrence of RA-related organizing pneumonia?
The recurrence rate of organizing pneumonia (OP) associated with rheumatoid arthritis (RA) is high, but OP does not appear to contribute to RA exacerbation, suggests a study. Several factors predicting OP recurrence have been identified, such as smoking and lower age at OP onset.
Which factors predict recurrence of RA-related organizing pneumonia?
14 Nov 2023Shorter outshines longer DAPT for ACS patients following DES implantation
In patients treated with drug-eluting stents (DES) for acute coronary syndrome (ACS), stopping aspirin within a month of dual antiplatelet therapy (DAPT) and continuing with ticagrelor alone outdid a 12-month DAPT regimen with ticagrelor and aspirin, findings from the T-PASS trial have shown.
Shorter outshines longer DAPT for ACS patients following DES implantation
14 Nov 2023177Lu-PSMA-617 improves rPFS vs ARPI switch in taxane-naïve mCRPC patients
The prostate-specific membrane antigen (PSMA)–targeted radioligand, lutetium-177 (177Lu)–PSMA-617, improves radiographic progression-free survival (rPFS) vs androgen receptor pathway inhibitor (ARPI) switch and has a favourable safety profile in taxane-naïve patients with metastatic castration-resistant prostate cancer (mCRPC) progressing on one prior second-generation ARPI, results of the phase III PSMAfore trial have shown.